Oregon Issues First Psilocybin Manufacturing License

March 29, 2023 · Ganjapreneur

Oregon regulators issued the state’s first business license under the state’s historic psilocybin therapy program last week, the Associated Press reports. The licensee, Satori Farms PDX LLC, received its license to begin manufacturing psilocybin products from Oregon Psilocybin Services — a branch of the Oregon Health Authority — last Wednesday.

Oregon’s medical psilocybin program formally launched this January after voters approved the system during the 2020 election.

Psilocybin, the psychedelic substance found in magic mushrooms, has shown promise in treating severe depression, post-traumatic stress disorder, end-of-life anxiety among the terminally ill, and some mental health conditions. While the substance remains outlawed at the federal level, the Food and Drug Administration (FDA) granted psilocybin mushrooms “breakthrough therapy” status for major depressive disorder in 2018, which has led to clinical trials.

Oregon Psilocybin Services has warned the program could be slow to come online, the report said, as regulators must first consider applications for four different types of licenses — manufacturing, laboratories, service centers, and facilitators.

Earlier this month also marked the culmination of the first-ever psilocybin training program by Portland-based InnerTrek, which teaches students how to accompany psilocybin patients during their psychedelic experiences, the report said.

Earlier this month, advocates launched the Psychedelic Medicine PAC, a new political action committee dedicated to supporting candidates for office who support the use of psychedelics for therapeutic purposes. (Full Story)

In category:Psychedelics
Next Post

Bipartisan Congressional Bill Would Force DEA To Let Patients Use Psychedelics And Marijuana

A bipartisan group of congressional lawmakers filed a bill this week to clarify that federal “Right to Try” (RTT) laws give seriously ill patients access to Schedule I drugs, including marijuana and psychedelics like psilocybin and MDMA. While the bipartisan…
Previous Post

Hawaii Health Department Says Legalizing Psychedelics Is A ‘More Meaningful’ Step Than Creating A Study Group

The Hawaii Department of Health (DOH) says that it would be prudent for the state to legalize certain psychedelics like psilocybin and MDMA to prepare for a likely federal policy change allowing their use for medical treatment. At a hearing…
Random Post

Numinus In Strong Position To Capture US$2.5 Billion Psychedelic-Assisted Therapy Market

As the COVID pandemic broke open quite clearly, never has there been a greater need for innovation to treat psychological disorders. With the World Health Organization (WHO) declaring mental health disorders as the leading cause of disability worldwide – nearly a billion…
Random Post

Gaby Just Says No to HempFusion Purchase

HempFusion now will explore options for bankruptcy.California-based Gaby Inc. (CSE: GABY) (OTCQB: GABLF) said that it will not be moving forward with the proposed transaction with HempFusion Wellness Inc., which the company announced on April 28. Gaby was going to…
Random Post

New Hampshire Marijuana Legalization Commission Takes Shape, With First Meeting To Consider State-Run Reform Model Set For Next Week

A New Hampshire commission tasked with preparing legislation to legalize marijuana sales through a system of state-run stores has officially been established, with members being appointed to the panel and a first meeting scheduled for next week. The governor signed a…
Random Post

Reaching Medical Cannabis Consumers: Helping Patients Thrive

In a time when adult-use cannabis seems to get all the attention, it’s important to remember that many people use the plant as medicine. There are millions of medical cannabis patients across the country, but this demographic is often cast aside as…